Temobenz 20/100/250 (Temozolomide capsules) is an oral chemotherapy drug, available in various strengths. It easily enters the cerebrospinal fluid and do not require hepatic metabolism for activation, thus providing 100% bioavailability. With enhanced bioavailability, it also provides ease of administration and improves patient compliance rates.
Indications & Usage
Temozolomide is indicated for treatment of adult patients with:
- Newly diagnosed glioblastoma multiforme (GBM) concomitantly with radiotherapy and then as maintenance treatment>
- Refractory anaplastic astrocytoma patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine
Limitations of Use
- Temozolomide is minimally effective for brain metastases from systemic cancers